CH616681A5 - - Google Patents

Download PDF

Info

Publication number
CH616681A5
CH616681A5 CH1019675A CH1019675A CH616681A5 CH 616681 A5 CH616681 A5 CH 616681A5 CH 1019675 A CH1019675 A CH 1019675A CH 1019675 A CH1019675 A CH 1019675A CH 616681 A5 CH616681 A5 CH 616681A5
Authority
CH
Switzerland
Prior art keywords
methyl
chloro
group
mixture
oxo
Prior art date
Application number
CH1019675A
Other languages
English (en)
French (fr)
Inventor
Saul Wolfe
Original Assignee
Univ Kingston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kingston filed Critical Univ Kingston
Publication of CH616681A5 publication Critical patent/CH616681A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH1019675A 1974-08-06 1975-08-05 CH616681A5 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB34614/74A GB1510794A (en) 1974-08-06 1974-08-06 1-oxacephems and intermediates therefor

Publications (1)

Publication Number Publication Date
CH616681A5 true CH616681A5 (no) 1980-04-15

Family

ID=10367850

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1019675A CH616681A5 (no) 1974-08-06 1975-08-05

Country Status (12)

Country Link
US (1) US4013653A (no)
JP (1) JPS5141385A (no)
AT (1) AT342769B (no)
BE (1) BE832174A (no)
CA (1) CA1052787A (no)
CH (1) CH616681A5 (no)
DE (1) DE2531843A1 (no)
DK (1) DK356075A (no)
FI (1) FI63237C (no)
FR (3) FR2281119A1 (no)
GB (1) GB1510794A (no)
NL (1) NL7509353A (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226866A (en) * 1972-11-06 1980-10-07 Merck & Co., Inc. Novel antibiotic analogues of cephalosporins
US4108992A (en) * 1975-05-10 1978-08-22 Beecham Group Limited Cephalosporin analogues and compositions
US4143038A (en) * 1975-11-12 1979-03-06 Shionogi & Co., Ltd. Cephalosporin analogues
CA1085392A (en) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporins
JPS607635B2 (ja) * 1976-04-27 1985-02-26 塩野義製薬株式会社 オキサゾリジン化合物
US4197402A (en) * 1976-08-09 1980-04-08 Shionogi & Co., Ltd. Cephalosporin analogues
JPS609515B2 (ja) * 1976-08-09 1985-03-11 塩野義製薬株式会社 3′−ノルオキサセファロスポリン類
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
US4089956A (en) * 1976-09-08 1978-05-16 Smithkline Corporation 7-Acylamino-8-oxo-3-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives and bactericidal compositions and use thereof
US4187375A (en) * 1976-09-08 1980-02-05 Smithkline Corporation Process for preparing oxazine ring compounds
US4443598A (en) * 1977-02-15 1984-04-17 Shionogi & Co., Ltd. 1-Oxadethiacepham compounds
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
US4478997A (en) * 1977-02-15 1984-10-23 Shionogi & Co., Ltd. 1-Oxadethiacepham compounds
JPS53105491A (en) 1977-02-25 1978-09-13 Shionogi & Co Ltd Oxazolinoazethidinylbutyrylic acid derivatives
CA1100962A (en) * 1977-04-28 1981-05-12 Yoshio Hamashima Haloarylmalonamidooxacephalosporins
IT1102408B (it) * 1977-12-23 1985-10-07 Fujisawa Pharmaceutical Co Composti analoghi della cefalosforina e procedimenti per la loro preparazione
US4243588A (en) * 1979-06-19 1981-01-06 Eli Lilly And Company Process for novel oxazolinoazetidinones
JPS5690088A (en) * 1979-11-02 1981-07-21 Meiji Seika Kaisha Ltd Novel cephalosporin analog compound
US4301282A (en) * 1980-09-17 1981-11-17 Eli Lilly And Company 1-Oxa-β-lactam antibiotics
US4368156A (en) * 1981-03-09 1983-01-11 Eli Lilly And Company Preparation of 4-haloazetidin-2-ones from 4-sulfinoazetidin-2-ones
US4500456A (en) * 1981-03-09 1985-02-19 Eli Lilly And Company Preparation of 4-fluoroazetidinones using FClO3
US4391975A (en) * 1981-12-15 1983-07-05 Queen's University At Kingston Process for 1-oxacephem derivatives
DE3225269A1 (de) * 1982-07-06 1984-01-12 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 7-amino-1-dethia-1-oxa-3-hydroxymethyl-cephem-4-carbonsaeuren
JPS59104389A (ja) * 1982-12-06 1984-06-16 Shionogi & Co Ltd オキサセファム誘導体
US4558123A (en) * 1983-07-22 1985-12-10 Eli Lilly And Company 3-Exomethylene cephalosporins
JP2525170B2 (ja) * 1987-03-09 1996-08-14 大塚製薬株式会社 2―オキサイソセフェム誘導体の製造方法
US5412094A (en) * 1993-06-28 1995-05-02 Eli Lilly And Company Bicyclic beta-lactam/paraben complexes
SK13897A3 (en) 1996-02-06 1998-05-06 Pliva Pharm & Chem Works 3-bromo- and 3,3-dibromo-4-oxo-1-azetidines, method for preparation thereof and their use
HRP970146A2 (en) * 1997-03-13 1998-10-31 Mice Kovacevic Epoxi-azetidines, preparation and use
AU2002322247A1 (en) * 2001-08-03 2003-02-17 Chirologix Pharmaceutical Inc. Antibacterial oxazinones and methods for their use and synthesis
WO2003018565A1 (en) * 2001-08-29 2003-03-06 Chirologix Pharmaceuticals Inc. Method for synthesizing oxazinones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1914366A1 (de) * 1969-03-21 1970-10-01 Bayer Ag Arzneimittel auf Basis neuer,heterocyclischer Verbindungen
DE2225697A1 (de) * 1971-05-28 1972-12-14 Eh Lilly and Co , Indianapolis, Ind (VStA) Neue beta Lactamverbindungen und Ver fahren zu ihrer Herstellung

Also Published As

Publication number Publication date
FI63237C (fi) 1983-05-10
FR2318158B1 (no) 1979-03-23
JPS5141385A (en) 1976-04-07
DE2531843A1 (de) 1976-02-19
BE832174A (fr) 1975-12-01
DK356075A (da) 1976-02-07
AT342769B (de) 1978-04-25
FR2318157B1 (no) 1979-03-09
ATA599175A (de) 1977-08-15
NL7509353A (nl) 1976-02-10
FR2281119B1 (no) 1982-04-23
US4013653A (en) 1977-03-22
GB1510794A (en) 1978-05-17
FI63237B (fi) 1983-01-31
FR2318158A1 (fr) 1977-02-11
FR2281119A1 (fr) 1976-03-05
CA1052787A (en) 1979-04-17
FR2318157A1 (fr) 1977-02-11
FI752225A (no) 1976-02-07

Similar Documents

Publication Publication Date Title
CH616681A5 (no)
CH647242A5 (fr) Esters benzyliques d'acides 6-hydroxyalkylpenicillaniques.
LU86461A1 (fr) Procede de deprotection des esters et ethers allyliques
LU86402A1 (fr) Acide 7-amino-3-propenylcephalosporanique et ses esters
FR2611718A1 (fr) Analogues d'amino prostaglandines 7-oxabicycloheptane substitues, a action therapeutique
FR2587343A1 (fr) Analogues de 7-oxabicycloheptane oxa prostaglandines a action therapeutique
US4200571A (en) 4-Chloroazetidinone
CH640537A5 (fr) Procede de preparation de 3-exomethylenecepham-sulfoxydes.
FR2607816A1 (fr) Nouveaux produits steroides comportant, en position 23, un radical sulfinyle, leur procede de preparation, leur application a la preparation de produits de la serie des 20-cetopregnanes et des intermediaires de cette preparation
Sheehan et al. Synthesis and reactions of 7-hydrazonocephalosporanates
BE863998A (fr) 1-oxadethiacephames
JPS58192874A (ja) 新規スピロイソキサゾリン誘導体
BE884145R (fr) Composes indoliques nouveaux
JPS6044298B2 (ja) アゼチジン‐2‐オン類およびその製法
CH476658A (fr) Procédé pour la préparation d'une dihydroxy-dicétone
BE892370A (fr) Nouveau procede de preparation de derives de la penicilline et de la cephalosporine
JPH021826B2 (no)
CH615909A5 (en) Process for the preparation of base compounds for the synthesis of prostaglandins
LU82458A1 (fr) Nouveaux derives d'acide penicillanique substitues en 6- et 6- et leur procede de production
LU84568A1 (fr) Nouveaux derives heterocycliques d'acide acetique et procede pour leur preparation
FR2474037A1 (fr) Nouveaux acides 16,17-dihydropregnene-21-carboxyliques et leurs derives utiles notamment comme anti-inflammatoires
BE887618A (fr) Beta-lactames des series de la cephalosporine et de la penicilline, leur preparation et leur utilisation comme antibiotiques
FR2586687A1 (fr) Procede de synthese et nouveaux derives de l'acide a, l-iduronique
JPH0242835B2 (no)
CH617176A5 (en) Process for the preparation of new cyclopentanone derivatives

Legal Events

Date Code Title Description
PL Patent ceased